Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Randomized trial of house dust mite sublingual immunotherapy tablets in preschool children with allergic rhinitis
jRCT1031200292Completed
- Sponsor
- National Hospital Organization
- Start
- Jan 2021
- Modality
- Subcutaneous Immunotherapy → Allergy Immunotherapy → Therapeutic Vaccines → Vaccines & Immunotherapeutics, Sublingual Immunotherapy → Allergy Immunotherapy → Therapeutic Vaccines → Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Randomised trial of standardized house dust mite extract in allergic rhinitis (AR) (2 arms), sponsored by National Hospital Organization. Primary endpoint: Improvement in nasal and eye symptom scores after 1 year. Started Jan 2021; status: completed.
02
Drugs
standardized house dust mite extract
03
Conditions
allergic rhinitis (AR)
Beyond the preview
Go deeper on jRCT1031200292.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT1031200292.